Effect of neoadjuvant chemotherapy on EC50 of propofol administered by TCI causing loss of consciousness in breast cancer patients
10.3760/cma.j.issn.0254-1416.2010.03.005
- VernacularTitle:新辅助化疗对乳腺癌患者靶控输注异丙酚意识消失时半数有效效应室靶浓度的影响
- Author:
Zijing HE
;
Zhihong LI
;
Yonghua HU
;
Zhiyi FAN
- Publication Type:Journal Article
- Keywords:
Chemotherapy,adjuvant;
Propofol;
Drug delivery systems;
Dose-response relationship,drug
- From:
Chinese Journal of Anesthesiology
2010;30(3):273-275
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of neoadjuvant chemotherapy on EC50 of propofol given by TCI which produces loss of consciousness (LOC) in breast cancer patients.Methods Ninety ASA Ⅰ or Ⅱ breast cancer patients aged 30-60 yr scheduled for elective surgery were allocated into 3 groups according to the chemotherapy the patients received (n=30 each):group Ⅰ control (group C) received no chemotherapy;group Ⅱ taxol and group Ⅲ adriamycine+cyclophosphamide+5-Fu.The patients were unpremedicated.The EC50 of propofol given by TCI was determined by up-and-down technique.The initial effect-site concentration (Ce) of propofol was 2.07μg/ml and the ratio between the 2 successive Ce was 1.09.Loss of response to verbal command and eyelash stimulation was used as sighs of LOC.The EC50 of propofol was calculated.Results The EC50 of propofol causing LOC was significantly lower in group Ⅱ and Ⅲ than in control group.There was no significant difference in the EC50 of propofol which produces LOC between group Ⅱ and Ⅲ.Conclusion The EC50 of propofol causing LOC in breast cancerpatients is decreased by adjuvant chemotherapy.
